Literature DB >> 28712806

Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.

Robert K Y Cheng1, Elena Segala1, Nathan Robertson1, Francesca Deflorian1, Andrew S Doré1, James C Errey1, Cédric Fiez-Vandal1, Fiona H Marshall1, Robert M Cooke2.   

Abstract

The adenosine A1 and A2A receptors belong to the purinergic family of G protein-coupled receptors, and regulate diverse functions of the cardiovascular, respiratory, renal, inflammation, and CNS. Xanthines such as caffeine and theophylline are weak, non-selective antagonists of adenosine receptors. Here we report the structure of a thermostabilized human A1 receptor at 3.3 Å resolution with PSB36, an A1-selective xanthine-based antagonist. This is compared with structures of the A2A receptor with PSB36 (2.8 Å resolution), caffeine (2.1 Å), and theophylline (2.0 Å) to highlight features of ligand recognition which are common across xanthines. The structures of A1R and A2AR were analyzed to identify the differences that are important selectivity determinants for xanthine ligands, and the role of T2707.35 in A1R (M2707.35 in A2AR) in conferring selectivity was confirmed by mutagenesis. The structural differences confirmed to lead to selectivity can be utilized in the design of new subtype-selective A1R or A2AR antagonists.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PSB36; adenosine A1 receptor structure; adenosine A2A receptor structure; caffeine; theophylline; xanthine

Mesh:

Substances:

Year:  2017        PMID: 28712806     DOI: 10.1016/j.str.2017.06.012

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  59 in total

1.  Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.

Authors:  Jinha Yu; Philip Mannes; Young-Hwan Jung; Antonella Ciancetta; Amelia Bitant; David I Lieberman; Sami Khaznadar; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2018-10-18       Impact factor: 3.597

2.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

3.  Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution.

Authors:  Dilip K Tosh; Veronica Salmaso; Harsha Rao; Amelia Bitant; Courtney L Fisher; David I Lieberman; Helmut Vorbrüggen; Marc L Reitman; Oksana Gavrilova; Zhan-Guo Gao; John A Auchampach; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2020-04-09       Impact factor: 7.446

Review 4.  New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.

Authors:  Elizabeth A Vecchio; Jo-Anne Baltos; Anh T N Nguyen; Arthur Christopoulos; Paul J White; Lauren T May
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

5.  Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor.

Authors:  Matthew T Eddy; Ming-Yue Lee; Zhan-Guo Gao; Kate L White; Tatiana Didenko; Reto Horst; Martin Audet; Pawel Stanczak; Kyle M McClary; Gye Won Han; Kenneth A Jacobson; Raymond C Stevens; Kurt Wüthrich
Journal:  Cell       Date:  2017-12-28       Impact factor: 41.582

Review 6.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

7.  Design and in Vivo Characterization of A1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series.

Authors:  Dilip K Tosh; Harsha Rao; Amelia Bitant; Veronica Salmaso; Philip Mannes; David I Lieberman; Kelli L Vaughan; Julie A Mattison; Amy C Rothwell; John A Auchampach; Antonella Ciancetta; Naili Liu; Zhenzhong Cui; Zhan-Guo Gao; Marc L Reitman; Oksana Gavrilova; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-01-03       Impact factor: 7.446

8.  Tritium-labeled agonists as tools for studying adenosine A2B receptors.

Authors:  Sonja Hinz; Wessam M Alnouri; Ulrich Pleiss; Christa E Müller
Journal:  Purinergic Signal       Date:  2018-05-11       Impact factor: 3.765

9.  A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states.

Authors:  Antonella Ciancetta; Priscila Rubio; David I Lieberman; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2019-11-22       Impact factor: 3.686

10.  Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.

Authors:  Shahrooz Nasrollahi-Shirazi; Daniel Szöllösi; Qiong Yang; Edin Muratspahic; Ali El-Kasaby; Sonja Sucic; Thomas Stockner; Christian Nanoff; Michael Freissmuth
Journal:  Mol Pharmacol       Date:  2020-09       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.